1st Quarter - Amendment
BLANK ROME GOVERNMENT RELATIONS for MYLAN LABORATORIES INC
Client
Income
$50,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 18, 2008 | $50,000 | Replaced |
| 1st Quarter - Amendment | Jul 30, 2010 | $50,000 | Replaced |
| 1st Quarter - Amendment (this page) | Aug 3, 2010 | $50,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the generic drug industry, authorized generics, patent settlement, citizen petitions, generic biologics, Medicaid/Medicare, BioShield, President's Emergency Plan for AIDS Relief (PEPFAR) and FDA issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY BOBEK | — |
| MICHELLE CASTRO | — |
| ASHLEY DAVIS | — |
| JAMES DREWRY | — |
| JOHN MANISCALCO | — |
| PETER A PEYSER | — |
| KRISTI REMINGTON | Deputy Attorney General |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.